Characteristic |  | Non-severe CAP (n = 639) | Severe CAP (n = 79) | p |
---|---|---|---|---|
Demographic data | Â | Â | Â | Â |
Sex [n(%)] | Female | 284 (44.4) | 27 (34.2) | 0.106 |
 | Male | 355 (55.6) | 52 (65.8) |  |
Age [n(%)] | < 65 | 229 (35.8) | 31 (39.2) | 0.639 |
 | ≥ 65 | 410 (64.2) | 48 (60.8) |  |
Current smoker [n(%)] | 0 | 478 (74.9) | 58 (73.4) | 0.878 |
 | 1 | 160 (25.1) | 21 (26.6) |  |
Alcohol abuse [n(%)] | 0 | 593 (92.9) | 74 (93.7) | 0.997 |
 | 1 | 45 ( 7.1) | 5 ( 6.3) |  |
Temperature < 36.3 °C or ≥ 37.2 °C [n(%)] | 0 | 108 (16.9) | 7 ( 8.9) | 0.094 |
 | 1 | 531 (83.1) | 72 (91.1) |  |
Comorbid condition | Â | Â | Â | Â |
Hypertension [n(%)] | 0 | 296 (46.3) | 27 (34.2) | 0.054 |
 | 1 | 343 (53.7) | 52 (65.8) |  |
Chronic respiratory disease [n(%)] | 0 | 542 (84.8) | 58 (73.4) | 0.016 |
 | 1 | 97 (15.2) | 21 (26.6) |  |
Cardiac dysfunction [n(%)] | 0 | 534 (83.6) | 54 (68.4) | 0.002 |
 | 1 | 105 (16.4) | 25 (31.6) |  |
Cerebrovascular disease [n(%)] | 0 | 549 (85.9) | 64 (81.0) | 0.320 |
 | 1 | 90 (14.1) | 15 (19.0) |  |
Chronic kidney dysfunction [n(%)] | 0 | 603 (94.4) | 62 (78.5) | < 0.001 |
 | 1 | 36 ( 5.6) | 17 (21.5) |  |
Rheumatic disorders [n(%)] | 0 | 627 (98.1) | 76 (96.2) | 0.479 |
 | 1 | 12 ( 1.9) | 3 ( 3.8) |  |
Malignant tumor [n(%)] | 0 | 606 (94.8) | 64 (81.0) | < 0.001 |
 | 1 | 33 ( 5.2) | 15 (19.0) |  |
Long-term glucocorticoid medication [n(%)] | 0 | 625 (97.8) | 73 (92.4) | 0.017 |
 | 1 | 14 ( 2.2) | 6 ( 7.6) |  |
Laboratory data | Â | Â | Â | Â |
Neu < 2 or ≥ 7*10^9/L [n(%)] | 0 | 369 (57.7) | 17 (21.5) | < 0.001 |
 | 1 | 270 (42.3) | 62 (78.5) |  |
L < 0.8 or ≥ 4*10^9/L [n(%)] | 0 | 467 (73.1) | 38 (48.1) | < 0.001 |
 | 1 | 172 (26.9) | 41 (51.9) |  |
PLT < 85 or ≥ 300*10^9/L [n(%)] | 0 | 491 (76.8) | 58 (73.4) | 0.592 |
 | 1 | 148 (23.2) | 21 (26.6) |  |
ALB < 35 g/L [n(%)] | 0 | 298 (46.6) | 5 ( 6.3) | < 0.001 |
 | 1 | 341 (53.4) | 74 (93.7) |  |
HbA1c > 42.07mmol/mol [n(%)] | 0 | 106 (16.6) | 1 ( 1.3) | 0.001 |
 | 1 | 533 (83.4) | 78 (98.7) |  |